These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23399560)

  • 1. Moderate hearing loss associated with a novel KCNQ4 non-truncating mutation located near the N-terminus of the pore helix.
    Watabe T; Matsunaga T; Namba K; Mutai H; Inoue Y; Ogawa K
    Biochem Biophys Res Commun; 2013 Mar; 432(3):475-9. PubMed ID: 23399560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico modeling of the pore region of a KCNQ4 missense mutant from a patient with hearing loss.
    Namba K; Mutai H; Kaneko H; Hashimoto S; Matsunaga T
    BMC Res Notes; 2012 Mar; 5():145. PubMed ID: 22420747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel frameshift mutation in KCNQ4 in a family with autosomal recessive non-syndromic hearing loss.
    Wasano K; Mutai H; Obuchi C; Masuda S; Matsunaga T
    Biochem Biophys Res Commun; 2015 Aug; 463(4):582-6. PubMed ID: 26036578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing loss.
    Talebizadeh Z; Kelley PM; Askew JW; Beisel KW; Smith SD
    Hum Mutat; 1999; 14(6):493-501. PubMed ID: 10571947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel KCNQ4 one-base deletion in a large pedigree with hearing loss: implication for the genotype-phenotype correlation.
    Kamada F; Kure S; Kudo T; Suzuki Y; Oshima T; Ichinohe A; Kojima K; Niihori T; Kanno J; Narumi Y; Narisawa A; Kato K; Aoki Y; Ikeda K; Kobayashi T; Matsubara Y
    J Hum Genet; 2006; 51(5):455-460. PubMed ID: 16596322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic effects of a novel mutation (c.664_681del) in KCNQ4 channels associated with auditory pathology.
    Baek JI; Park HJ; Park K; Choi SJ; Lee KY; Yi JH; Friedman TB; Drayna D; Shin KS; Kim UK
    Biochim Biophys Acta; 2011 Apr; 1812(4):536-43. PubMed ID: 20832469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel mutations in the KCNQ4 gene of patients with nonsyndromic deafness from Taiwan.
    Su CC; Yang JJ; Shieh JC; Su MC; Li SY
    Audiol Neurootol; 2007; 12(1):20-6. PubMed ID: 17033161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Japanese family showing high-frequency hearing loss with KCNQ4 and TECTA mutations.
    Ishikawa K; Naito T; Nishio SY; Iwasa Y; Nakamura K; Usami S; Ichimura K
    Acta Otolaryngol; 2014 Jun; 134(6):557-63. PubMed ID: 24655070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss.
    Jung J; Choi HB; Koh YI; Rim JH; Choi HJ; Kim SH; Lee JH; An J; Kim A; Lee JS; Joo SY; Yu S; Choi JY; Kang TM; Gee HY
    Sci Rep; 2018 Nov; 8(1):16659. PubMed ID: 30413759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [KCNQ4 gene mutations affected a pedigree with autosomal dominant hereditary hearing loss].
    Wang Q; Cao J; Li N; Yang Y; Wang Q; Yu L; Han D; Yang W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Oct; 37(5):343-7. PubMed ID: 12772453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression.
    Mencía A; González-Nieto D; Modamio-Høybjør S; Etxeberría A; Aránguez G; Salvador N; Del Castillo I; Villarroel A; Moreno F; Barrio L; Moreno-Pelayo MA
    Hum Genet; 2008 Feb; 123(1):41-53. PubMed ID: 18030493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCNQ4 mutations associated with nonsyndromic progressive sensorineural hearing loss.
    Nie L
    Curr Opin Otolaryngol Head Neck Surg; 2008 Oct; 16(5):441-4. PubMed ID: 18797286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recurrent mutation in KCNQ4 in Korean families with nonsyndromic hearing loss and rescue of the channel activity by KCNQ activators.
    Shin DH; Jung J; Koh YI; Rim JH; Lee JS; Choi HJ; Joo SY; Yu S; Cha DH; Lee SY; Lee JH; Lee MG; Choi JY; Gee HY
    Hum Mutat; 2019 Mar; 40(3):335-346. PubMed ID: 30556268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family.
    Cui C; Zhang L; Qian F; Chen Y; Huang B; Wang F; Wang D; Lv J; Wang X; Yan Z; Guo L; Li GL; Shu Y; Liu D; Li H
    Clin Genet; 2022 Aug; 102(2):149-154. PubMed ID: 35599357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus.
    Hildebrand MS; Tack D; McMordie SJ; DeLuca A; Hur IA; Nishimura C; Huygen P; Casavant TL; Smith RJ
    Genet Med; 2008 Nov; 10(11):797-804. PubMed ID: 18941426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic features of nonsyndromic autosomal dominant sensorineural hearing loss: KCNQ4 is a gene responsible in Japanese.
    Akita J; Abe S; Shinkawa H; Kimberling WJ; Usami S
    J Hum Genet; 2001; 46(7):355-61. PubMed ID: 11450843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment.
    Jung J; Lin H; Koh YI; Ryu K; Lee JS; Rim JH; Choi HJ; Lee HJ; Kim HY; Yu S; Jin H; Lee JH; Lee MG; Namkung W; Choi JY; Gee HY
    Exp Mol Med; 2019 Aug; 51(8):1-12. PubMed ID: 31434872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    Lee SY; Choi HB; Park M; Choi IS; An J; Kim A; Kim E; Kim N; Han JH; Kim MY; Lee SM; Oh DY; Kim BJ; Yi N; Kim NKD; Lee C; Park WY; Koh YI; Gee HY; Cho HS; Kang TM; Choi BY
    Exp Mol Med; 2021 Jul; 53(7):1192-1204. PubMed ID: 34316018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlooked KCNQ4 variants augment the risk of hearing loss.
    Oh KS; Roh JW; Joo SY; Ryu K; Kim JA; Kim SJ; Jang SH; Koh YI; Kim DH; Kim HY; Choi M; Jung J; Namkung W; Nam JH; Choi JY; Gee HY
    Exp Mol Med; 2023 Apr; 55(4):844-859. PubMed ID: 37009795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss.
    Rim JH; Choi JY; Jung J; Gee HY
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.